Dahlene N. Fusco, Ph.D. - Publications

Affiliations: 
2004 Yeshiva University, New York, NY, United States 
Area:
Cell Biology

3/51 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2004 Shav-Tal Y, Darzacq X, Shenoy SM, Fusco D, Janicki SM, Spector DL, Singer RH. Dynamics of single mRNPs in nuclei of living cells. Science (New York, N.Y.). 304: 1797-800. PMID 15205532 DOI: 10.1126/Science.1099754  0.402
2004 Fusco D, Bertrand E, Singer RH. Imaging of single mRNAs in the cytoplasm of living cells. Progress in Molecular and Subcellular Biology. 35: 135-50. PMID 15113083 DOI: 10.1007/978-3-540-74266-1_7  0.5
2003 Fusco D, Accornero N, Lavoie B, Shenoy SM, Blanchard JM, Singer RH, Bertrand E. Single mRNA molecules demonstrate probabilistic movement in living mammalian cells. Current Biology : Cb. 13: 161-7. PMID 12546792 DOI: 10.1016/S0960-9822(02)01436-7  0.542
Low-probability matches (unlikely to be authored by this person)
2015 Lin W, Zhu C, Hong J, Zhao L, Jilg N, Fusco DN, Schaefer EA, Brisac C, Liu X, Peng LF, Xu Q, Chung RT. The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing. Journal of Hepatology. 62: 1024-32. PMID 25481564 DOI: 10.1016/j.jhep.2014.11.038  0.282
2023 Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, ... ... Fusco DN, et al. Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. Medrxiv : the Preprint Server For Health Sciences. PMID 37333252 DOI: 10.1101/2023.06.06.23290973  0.176
2013 Fusco DN, Brisac C, John SP, Huang YW, Chin CR, Xie T, Zhao H, Jilg N, Zhang L, Chevaliez S, Wambua D, Lin W, Peng L, Chung RT, Brass AL. A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication. Gastroenterology. 144: 1438-49, 1449.e1-9. PMID 23462180 DOI: 10.1053/j.gastro.2013.02.026  0.155
2023 Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, ... ... Fusco DN, et al. Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. The Journal of Infectious Diseases. PMID 37561027 DOI: 10.1093/infdis/jiad323  0.142
2017 Fusco DN, Pratt H, Kandilas S, Cheon SS, Lin W, Cronkite DA, Basavappa M, Jeffrey KL, Anselmo A, Sadreyev R, Yapp C, Shi X, O'Sullivan JF, Gerszten RE, Tomaru T, et al. HELZ2 Is an IFN Effector Mediating Suppression of Dengue Virus. Frontiers in Microbiology. 8: 240. PMID 28265266 DOI: 10.3389/fmicb.2017.00240  0.132
2023 Branche AR, Rouphael NG, Losada C, Baden LR, Anderson EJ, Luetkemeyer AF, Diemert DJ, Winokur PL, Presti RM, Kottkamp AC, Falsey AR, Frey SE, Rupp R, Bäcker M, Novak RM, ... ... Fusco DN, et al. Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 37036397 DOI: 10.1093/cid/ciad209  0.12
2023 Branche AR, Rouphael NG, Losada C, Baden LR, Anderson EJ, Luetkemeyer AF, Diemert DJ, Winokur PL, Presti RM, Kottkamp AC, Falsey AR, Frey SE, Rupp R, Bäcker M, Novak RM, ... ... Fusco DN, et al. Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial. Medrxiv : the Preprint Server For Health Sciences. PMID 37034641 DOI: 10.1101/2023.01.31.23285306  0.12
2016 Salloum S, Holmes JA, Jindal R, Bale SS, Brisac C, Alatrakchi N, Lidofsky A, Kruger A, Fusco DN, Luther J, Schaefer E, Lin W, Yarmush ML, Chung RT. HIV/HCV in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types. Hepatology (Baltimore, Md.). PMID 27531241 DOI: 10.1002/Hep.28766  0.119
2015 Zhu C, Xiao F, Hong J, Wang K, Liu X, Cai D, Fusco DN, Zhao L, Jeong SW, Brisac C, Chusri P, Schaefer EA, Zhao H, Peng LF, Lin W, et al. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway. Journal of Virology. 89: 6608-18. PMID 25878102 DOI: 10.1128/JVI.00364-15  0.114
2013 Bai H, Chen T, Ming J, Sun H, Cao P, Fusco DN, Chung RT, Chorev M, Jin Q, Aktas BH. Dual activators of protein kinase R (PKR) and protein kinase R-like kinase PERK identify common and divergent catalytic targets. Chembiochem : a European Journal of Chemical Biology. 14: 1255-62. PMID 23784735 DOI: 10.1002/cbic.201300177  0.108
2023 Branche A, Rouphael N, Diemert D, Falsey A, Losada C, Baden LR, Frey S, Whitaker J, Little S, Anderson E, Walter E, Novak R, Rupp R, Jackson L, Babu T, ... ... Fusco D, et al. Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial. Research Square. PMID 37205592 DOI: 10.21203/rs.3.rs-2653179/v1  0.106
2023 Branche AR, Rouphael NG, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Anderson EJ, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, ... ... Fusco DN, et al. Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial. Nature Medicine. PMID 37640860 DOI: 10.1038/s41591-023-02503-4  0.106
2012 Kumthip K, Chusri P, Jilg N, Zhao L, Fusco DN, Zhao H, Goto K, Cheng D, Schaefer EA, Zhang L, Pantip C, Thongsawat S, O'Brien A, Peng LF, Maneekarn N, et al. Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling. Journal of Virology. 86: 8581-91. PMID 22674974 DOI: 10.1128/JVI.00533-12  0.103
2018 Eddowes LA, Al-Hourani K, Ramamurthy N, Frankish J, Baddock HT, Sandor C, Ryan JD, Fusco DN, Arezes J, Giannoulatou E, Boninsegna S, Chevaliez S, Owens BMJ, Sun CC, Fabris P, et al. Antiviral activity of bone morphogenetic proteins and activins. Nature Microbiology. PMID 30510168 DOI: 10.1038/S41564-018-0301-9  0.087
2014 Jilg N, Lin W, Hong J, Schaefer EA, Wolski D, Meixong J, Goto K, Brisac C, Chusri P, Fusco DN, Chevaliez S, Luther J, Kumthip K, Urban TJ, Peng LF, et al. Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus. Hepatology (Baltimore, Md.). 59: 1250-61. PMID 23913866 DOI: 10.1002/Hep.26653  0.084
2020 Huang Z, Tian D, Liu Y, Lin Z, Lyon CJ, Lai W, Fusco D, Drouin A, Yin X, Hu T, Ning B. Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis. Biosensors & Bioelectronics. 164: 112316. PMID 32553350 DOI: 10.1016/j.bios.2020.112316  0.082
2021 Drouin AC, Theberge MW, Liu SY, Smither AR, Flaherty SM, Zeller M, Geba GP, Reynaud P, Rothwell WB, Luk AP, Tian D, Boisen ML, Branco LM, Andersen KG, Robinson JE, ... ... Fusco DN, et al. Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail. Viruses. 13. PMID 34201591 DOI: 10.3390/v13071202  0.078
2018 Duan X, Li S, Holmes JA, Tu Z, Li Y, Cai D, Liu X, Li W, Yang C, Jiao B, Schaefer EA, Fusco DN, Salloum S, Chen L, Lin W, et al. MicroRNA-130a regulates both HCV and HBV replication through a central metabolic pathway. Journal of Virology. PMID 29321333 DOI: 10.1128/JVI.02009-17  0.076
2021 Zeller M, Gangavarapu K, Anderson C, Smither AR, Vanchiere JA, Rose R, Dudas G, Snyder DJ, Watts A, Matteson NL, Robles-Sikisaka R, Marshall M, Feehan AK, Sabino-Santos G, Bell-Kareem A, ... ... Fusco DN, et al. Emergence of an early SARS-CoV-2 epidemic in the United States. Medrxiv : the Preprint Server For Health Sciences. PMID 33564781 DOI: 10.1101/2021.02.05.21251235  0.071
2010 Fusco D, Krawitz P, LaRussa P, Steinberg S, Gershon A, Jacobs J. VZV meningitis following varicella vaccine. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 48: 275-7. PMID 20542464 DOI: 10.1016/j.jcv.2010.04.014  0.062
2010 Fusco D, Liu X, Savage C, Taur Y, Xiao W, Kennelly E, Yuan J, Cassileth B, Salvatore M, Papanicolaou GA. Echinacea purpurea aerial extract alters course of influenza infection in mice. Vaccine. 28: 3956-62. PMID 20382242 DOI: 10.1016/J.Vaccine.2010.03.047  0.061
2022 Branche AR, Rouphael NG, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Anderson EJ, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, ... ... Fusco DN, et al. SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses. Medrxiv : the Preprint Server For Health Sciences. PMID 35898343 DOI: 10.1101/2022.07.12.22277336  0.06
2021 Chatwani B, Flaherty S, Liu S, Theberge M, Zeller M, Anderson K, Boisen M, Branco L, Garry R, Drouin A, Fusco D. 289. Post COVID Syndrome Cohort Characterization Open Forum Infectious Diseases. 8: S251-S252. DOI: 10.1093/ofid/ofab466.491  0.058
2016 Chusri P, Kumthip K, Hong J, Zhu C, Duan X, Jilg N, Fusco DN, Brisac C, Schaefer EA, Cai D, Peng LF, Maneekarn N, Lin W, Chung RT. HCV induces transforming growth factor β1 through activation of endoplasmic reticulum stress and the unfolded protein response. Scientific Reports. 6: 22487. PMID 26927933 DOI: 10.1038/srep22487  0.057
2012 Fusco DN, Chung RT. Novel therapies for hepatitis C: insights from the structure of the virus. Annual Review of Medicine. 63: 373-87. PMID 21942423 DOI: 10.1146/annurev-med-042010-085715  0.056
2018 Fusco DN, Ganova-Raeva L, Khudyakov Y, Punkova L, Mohamed A, Cheon SSY, Koirala P, Andersson KL, Jourdain G, Sureau C, Chung RT, Lauer G. Reactivation of a Vaccine Escape Hepatitis B Virus Mutant in a Cambodian Patient During Anti-Hepatitis C Virus Therapy. Frontiers in Medicine. 5: 97. PMID 29761102 DOI: 10.3389/fmed.2018.00097  0.053
2021 Zeller M, Gangavarapu K, Anderson C, Smither AR, Vanchiere JA, Rose R, Snyder DJ, Dudas G, Watts A, Matteson NL, Robles-Sikisaka R, Marshall M, Feehan AK, Sabino-Santos G, Bell-Kareem AR, ... ... Fusco DN, et al. Emergence of an early SARS-CoV-2 epidemic in the United States. Cell. PMID 34508652 DOI: 10.1016/j.cell.2021.07.030  0.051
2021 Ngo-Giang-Huong N, Leroi C, Fusco D, Cressey TR, Wangsaeng N, Salvadori N, Kongyai N, Sirirungsi W, Lallemant M, Auewarakul P, Khamduang W, Jourdain G. Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015. Viruses. 13. PMID 34452289 DOI: 10.3390/v13081423  0.051
2011 Zhang L, Jilg N, Shao RX, Lin W, Fusco DN, Zhao H, Goto K, Peng LF, Chen WC, Chung RT. IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway. Journal of Hepatology. 55: 289-98. PMID 21147189 DOI: 10.1016/j.jhep.2010.11.019  0.049
2013 Goto K, Lin W, Zhang L, Jilg N, Shao RX, Schaefer EA, Zhao H, Fusco DN, Peng LF, Kato N, Chung RT. The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling. Journal of Hepatology. 59: 942-8. PMID 23831117 DOI: 10.1016/j.jhep.2013.06.025  0.048
2013 Fierer DS, Dieterich DT, Fiel MI, Branch AD, Marks KM, Fusco DN, Hsu R, Smith DM, Fierer J. Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 1038-43. PMID 23264364 DOI: 10.1093/cid/cis1206  0.043
2013 Liu X, He Y, Xiao K, White JR, Fusco DN, Papanicolaou GA. Effect of linezolid on clinical severity and pulmonary cytokines in a murine model of influenza A and Staphylococcus aureus coinfection. Plos One. 8: e57483. PMID 23478252 DOI: 10.1371/journal.pone.0057483  0.042
2022 Murray DD, Grund B, MacPherson C, Ekenberg C, Zucco A, Reekie J, Dominguez-Dominguez L, Leung P, Fusco D, Gras J, Gerstoft J, Helleberg M, Borges ÁH, Polizzotto M, Lundgren JD. Association between TET2 genetic variation and viral load in people living with HIV. Aids (London, England). PMID 36473831 DOI: 10.1097/QAD.0000000000003427  0.041
2021 Dumonteil E, Fusco D, Drouin A, Herrera C. Genomic Signatures of SARS-CoV-2 Associated with Patient Mortality. Viruses. 13. PMID 33540576 DOI: 10.3390/v13020227  0.041
2024 Drouin A, Plumb ID, McCullough M, James Gist J, Liu S, Theberge M, Katz J, Moreida M, Flaherty S, Chatwani B, Briggs Hagen M, Midgley CM, Fusco D. Clinical and laboratory characteristics of patients hospitalized with severe COVID-19 in New Orleans, August 2020 to September 2021. Scientific Reports. 14: 6539. PMID 38503862 DOI: 10.1038/s41598-024-57306-5  0.04
2021 Borrega R, Nelson DKS, Koval AP, Bond NG, Heinrich ML, Rowland MM, Lathigra R, Bush DJ, Aimukanova I, Phinney WN, Koval SA, Hoffmann AR, Smither AR, Bell-Kareem AR, Melnik LI, ... ... Fusco DN, et al. Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans. Viruses. 13. PMID 34835131 DOI: 10.3390/v13112325  0.037
2016 Schaefer EA, Meixiong J, Mark C, Deik A, Motola DL, Fusco D, Yang A, Brisac C, Salloum S, Lin W, Clish CB, Peng LF, Chung RT. Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C. World Journal of Gastroenterology. 22: 9954-9965. PMID 28018102 DOI: 10.3748/wjg.v22.i45.9954  0.036
2013 Shao RX, Zhang L, Hong Z, Goto K, Cheng D, Chen WC, Jilg N, Kumthip K, Fusco DN, Peng LF, Chung RT. SOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication. Antiviral Research. 97: 101-7. PMID 23237992 DOI: 10.1016/j.antiviral.2012.12.001  0.036
2020 Sise ME, Strohbehn I, Chute D, Corey KE, Fusco DN, Sabbisetti VS, Waikar SS, Chung RT. Low Complement C4 Predicts Improvement of Kidney Function After Direct-Acting Antiviral Therapy for Hepatitis C Virus. Hepatology Communications. 4: 1206-1217. PMID 32766479 DOI: 10.1002/hep4.1528  0.035
2020 Drouin A, Wallbillich N, Theberge M, Liu S, Katz J, Bellovoda K, Se Yun Cheon S, Gootkind F, Bierman E, Zavras J, Berberich MJ, Kalocsay M, Guastaldi F, Salvadori N, Troulis M, ... Fusco DN, et al. Impact of Zika virus on the human type I interferon osteoimmune response. Cytokine. 137: 155342. PMID 33130337 DOI: 10.1016/j.cyto.2020.155342  0.034
2012 Zhao H, Lin W, Kumthip K, Cheng D, Fusco DN, Hofmann O, Jilg N, Tai AW, Goto K, Zhang L, Hide W, Jang JY, Peng LF, Chung RT. A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus. Journal of Hepatology. 56: 326-33. PMID 21888876 DOI: 10.1016/j.jhep.2011.07.026  0.032
2022 Borlotti A, Thomaides-Brears H, Georgiopoulos G, Banerjee R, Robson MD, Fusco DN, Masci PG. The Additive Value of Cardiovascular Magnetic Resonance in Convalescent COVID-19 Patients. Frontiers in Cardiovascular Medicine. 9: 854750. PMID 35463767 DOI: 10.3389/fcvm.2022.854750  0.025
2017 Djoufack R, Cheon SSY, Mohamed A, Faye F, Diouf K, Colvin R, Morrill J, Duffy-Keane AM, Perumalswami P, Jourdain G, Fusco D. Hepatitis B virus outreach to immigrant population in Greater Boston Area: Key to improving hepatitis B knowledge. World Journal of Gastroenterology. 23: 7626-7634. PMID 29204062 DOI: 10.3748/wjg.v23.i42.7626  0.023
2020 Alger J, Cafferata ML, Alvarado T, Ciganda A, Corrales A, Desale H, Drouin A, Fusco D, Garcia J, Gibbons L, Harville E, Lopez W, Lorenzana I, Muñoz-Lara F, Palou E, et al. Using Prenatal Blood Samples to Evaluate COVID-19 Rapid Serologic Tests Specificity. Maternal and Child Health Journal. PMID 32671537 DOI: 10.1007/S10995-020-02981-9  0.02
2011 Fusco DN, Chung RT. New protease inhibitors for HCV--help is on the way. Journal of Hepatology. 54: 1087-9. PMID 21232563 DOI: 10.1016/j.jhep.2010.12.016  0.018
2010 Fusco DN, Downs JA, Satlin MJ, Pahuja M, Ramos L, Barie PS, Fleckenstein L, Murray HW. Non-oral treatment with ivermectin for disseminated strongyloidiasis. The American Journal of Tropical Medicine and Hygiene. 83: 879-83. PMID 20889884 DOI: 10.4269/ajtmh.2010.10-0258  0.014
2009 Fusco DN, Alexander EL, Weisenberg SA, Mediavilla JR, Kreiswirth BN, Schuetz AN, Jenkins SG, Rhee KY. Clinical failure of vancomycin in a dialysis patient with methicillin-susceptible vancomycin-heteroresistant S. aureus. Diagnostic Microbiology and Infectious Disease. 65: 180-3. PMID 19748429 DOI: 10.1016/J.Diagmicrobio.2009.05.017  0.013
2011 Fusco DN, Chung RT. Corrigendum to ‘‘New protease inhibitors for HCV – Help is on the way’’ [J Hepatol 2011;54:1087–1089] Journal of Hepatology. 55: 952. DOI: 10.1016/J.JHEP.2011.05.009  0.012
Hide low-probability matches.